liver cirrhosis

Translocation of gut microbiota in liver cirrhosis: mechanisms, clinical significance, and markers

Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(2):147-160

10.36488/cmac.2021.2.147-160

This article is an overview of the data on bacterial intestinal translocation. The article reviews changes in the intestinal microbiome, the local physiological barrier, as well as the innate and adaptive immunity characteristics contributing to the …

Clinical case of difficult differential diagnosis between liver cirrhosis and hepatocellular carcinoma associated with HCV infection in a patient with prolonged alcohol exposure

Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(3):245-248

10.36488/cmac.2019.3.245-248

This paper presents a clinical case of large focal liver mass in a 55-year old patient with HCV-associated liver cirrhosis and prolonged high-dose alcohol exposure. Given the inconsistency between clinical data and ultrasound examination results as …

Bacterial infections in patients with liver cirrhosis

Clinical Microbiology and Antimicrobial Chemotherapy. 2017; 19(4):284-295

Patients with liver cirrhosis are at substantial risk of bacterial infections. Bacterial complications account for more than 30% of hospitalizations and contribute significantly to mortality among cirrhotic patients. The most common bacterial …

First Russian Experience of Successful Use of Caspofungin in Invasive Candidiasis in Patient with Severe Hepatic Failure (Clinical case)

Clinical Microbiology and Antimicrobial Chemotherapy. 2005; 7(4):403-409

A clinical case of the successful use of caspofungin for the treatment of invasive candidiasis, caused by fluconazole- and voriconazole-resistant strain of Candida glabrata, in the patient with severe hepatic failure (Child-Pugh score of 12) due to …